A (high quality) |
Very confident that the true effect value approximates the effect estimate |
B (moderate quality) |
There is a moderate degree of confidence in the effect estimates, and it is possible that the true value is close to the estimates, but there is still a possibility that the two are quite different |
C (poor quality) |
The degree of confidence in the effect estimate is limited and the true value may be quite different from the estimate |
D (very low quality) |
There is little confidence in the estimates of effects and the true values are likely to be very different from the estimates |
Strength of recommendations |
Level 1 recommendation (strong) |
The benefits clearly outweigh the risks and the credibility of both clinician implementation and population acceptance is high |
Level 2 recommendation (weak) |
The benefits are equal to the risks, depending on the specific clinical situation. In general, the preferences of doctors and patients play a more important role in the decision-making process |